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Keratoconus (KC) is a common corneal ectasia which is characterized by corneal thinning, irregular astigmatism, decreased visual acuity, and scarring.[@ref1] The prevalence of KC has been reported to be higher in Asians than white people.[@ref2] In the Iranian population, KC has a prevalence that has been estimated to be about 2.5-3.3%.[@ref3][@ref4]

The etiopathogenesis of KC is unclear, but previous studies have shown that an interplay between genetic and environmental factors affect its occurrence.[@ref5] Some theories have proposed the critical role of oxidative stress in KC formation and progression,[@ref6][@ref7] and molecular analysis has revealed alterations in the activity of proteases, over expression of cytokines and some matrix metalloproteinases (MMPs) in KC tear film compared with controls.[@ref8] There is alsoreportedto bea decreased activity of some proteins like catalase, glutathione, and superoxide dismutase (SOD) in KC which are involved in the process of free radical detoxification.[@ref9] Studies also have suggested the antioxidative role of 25-hydroxyvitamin D (25OHD) in amelioration of oxidative stress.[@ref10] Vitamin D receptor knockout decreases the wound healing rate of corneal epithelium in mice. It also affects the integrity of corneal tight junctions.[@ref11][@ref12] The idea for this study came from the highly reported prevalence of KC and vitamin D deficiency in the Middle East region[@ref3][@ref4][@ref13][@ref14][@ref15][@ref16] and the relative concordance of their prevalence in topographic maps which indicate a possible association between vitamin D deficiency and KC in people who live in this geographical area[@ref16] \[[Figure 1](#F1){ref-type="fig"}\]. In 2016, a prevalence of 79% of vitamin D deficiency was reported among 846 subjects who were randomly derived from the Mashhad study.[@ref17]

![Worldwide keratoconus (KC) prevalence has been matched to the prevalence map of Vitamin D deficiency (reproduced with permission from Palacios and Gonzales[@ref16])](JCO-32-26-g001){#F1}

Furthermore, the antioxidative role of some trace elements, especially in advanced KC, has been proposed.[@ref18] Keratoconic corneas show decreased activity of lysyl oxidase enzyme, which is important in corneal cross-linking, and Copper (Cu) is its co-factor.[@ref19][@ref20][@ref21] Selenium (Se) components can protect the cornea by regulating oxidative stress in the epithelium,[@ref22] and Zinc (Zn) supplementations down regulate the inflammatory cytokines and decrease oxidative stress.[@ref23] The prevalence of Zn and Cu deficiency has been reported to be 22.1% and 32.1% in Mashhad, respectively.[@ref24]

Moreover, it has been shown that intra and extra cellular imbalance of Magnesium (Mg) due to Mg deficiency can be related to KC.[@ref25]

To the best of the authors\' knowledge, this is the first study which evaluates a possible association between 25OHD plasma level and different stages of KC. We also compared serum levels of 25OHD and three major trace elements including Cu, Zn, and Se, between the KC and normal subjects.
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=====================

This cross-sectional study adheres to the tenets of the Declaration of Helsinki and was approved by the Ethical Committee of Mashhad University of Medical Sciences. One hundred keratoconic patients who presented to the Cornea service of Khatam Al-Anbia Eye Specialty Hospital, Mashhad, Iran and had no disorder other than KC were recruited. Written informed consent was obtained from all patients before enrollment. KC was diagnosed according to topography, Orbscan, (Bausch and Lomb, Rochester, NY, USA) parameters and clinical examination based on Collaborative Longitudinal Evaluation of Keratoconus (CLEK) study criteria defined as: distortion of the keratometry mires or retinoscopic reflex which indicates an irregular cornea, showing at least 1 of the ophthalmoscopic signs of Vogt\'s striae, more than 2 mm arc of Fleischer\'s ring or corneal scarring.[@ref26] Moreover, KC patients were classified into four stages according to Krumeich criteria[@ref27] and compared to 100 age- and sex-matched healthy subjects. The control group was normal subjects in the hospital who were mostly candidates for refractive surgery and were ruled out for KC (e.g., forme fruste, subclinical, and clinical KC).

All subjects had Iranian ethnicity and were residents of an urban community. Patients with a history of penetrating keratoplasty or any ocular surgery, corneal scarring, severe dry eye disease, glaucoma, or taking any antioxidant/vitamin or anti-inflammatory treatment were excluded.

Fasting blood samples were taken in the morning from all participants. Serum was separated by centrifugation for 10 min at 3000 rate per minute and kept at -80 degrees Celsius until it was analyzed. Blood samples were examined in the same laboratory and observed with the same circumstances.

After allowing the stored samples to equilibrate to room temperature, they were diluted with deionized water (10:1) for evaluation of Zn, Cu, and Se. Serum Cu was analyzed using auto analyzer system (Premium, Biorex, Japan) with colorimetric method. Serum Zn was analyzed with the same device using a kit purchased from Grainer (Frickenhausen, Germany) with colorimetric method. For evaluation of Se level, Flame atomic absorption system (Varian, USA) was used. Serum 25OHD was measured by HPLC system (Agilent, USA) with chromatographic method.[@ref28]

Statistical analysis was performed using IBM SPSS statistical software for Windows version 22 (IBM Co., Chicago, IL). Kolmogorov-Smirnov test was used to assess the normal distribution of data. Independent *t*-test and Mann-Whitney U tests were performed for comparison between groups. Categorical variables were analyzed using χ[@ref2] test. Mean serum trace elements were compared in four KC stages using one-way ANOVA or Kruskal Wallis-H tests. A multinomial logistic regression model was created to assess the affecting factors on severity of KC (KC stage), considering age, sex, 25OHD, Zn, Cu, Se serum level, and by convention, parameters with a significance level of *P* \< 0.2 between 4 KC stages were entered to the model. For all results, *P* \< 0.05 was considered statistically significant.
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In this study, 103 (51.5%) men and 97 (48.5%) women with a mean age of 26.30 ± 7.32 years in the KC group and 27.82 ± 6.97 years in the control group (*P* = 0.132) participated. The two groups were not significantly different regarding gender (*P* = 0.572). Among 100 KC patients, 38 patients were in stage 1, 24 in stage 2, 27 in stage 3, and 11 were in stage 4 of KC.
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### Comparison of the serum 25-hydroxyvitamin D level between the study groups {#sec3-1}

Mean serum 25OHD was significantly lower in the case group (*P* = 0.006) \[[Table 1](#T1){ref-type="table"}\]. Although a lower mean serum 25OHD was also found in patients with higher KC stages, it was not significantly different between the 4 KC stage groups (*P* = 0.441) \[[Table 2](#T2){ref-type="table"}\]. Also, in post hoc pairwise comparison between KC stage groups, there was no significant difference for serum 25OHD (*P* \> 0.05 for all).

###### 

Mean plasma 25-hydroxyvitamin D (25OHD), Zinc (Zn), Copper (Cu), Selenium (Se), Zn, and Cu in the keratoconus (KC) group compared with the control group

                  Normal range   Cases (*n*=100)   Controls (*n*=100)   *P*
  --------------- -------------- ----------------- -------------------- -------
  25OHD (ng/mL)   \>20-25        11.83±7.64        15.51±10.95          0.006
  Se (mg/L)       70-150         98.56±11.05       102.17±13.29         0.038
  Zn (mg/dL)      66-110         58.07±18.42       64.28±17.17          0.015
  Cu (mg/dL)      75-145         89.77±14.04       97.14±21.38          0.004
  Cu/Zn           1.12-1.27      1.76±0.92         1.62±0.54            0.168

25OHD: 25-hydroxyvitamin D, Zn: Zinc, Cu: Copper, Se: Selenium

###### 

Mean plasma 25-hydroxyvitamin D (25OHD), Selenium (Se), Zinc (Zn), and Copper (Cu) in the keratoconus (KC) stage^a^ groups

                  Stage I (*n*=38)   Stage II (*n*=24)   Stage III (*n*=27)   Stage IV (*n*=11)   *P*
  --------------- ------------------ ------------------- -------------------- ------------------- -------
  Age             25.84±6.78         26.75±7.37          25.89±7.05           27.81±10.05         0.854
  25OHD (ng/mL)   13.19±7.51         11.62±9.13          11.16±6.82           9.21±6.28           0.441
  Se (mg/L)       100.70±8.58        93.80±13.13         100.50±9.76          100.25±14.84        0.113
  Zn (mg/dL)      62.68±17.62        57.08±21.51         56.33±16.44          48.54±15.88         0.130
  Cu (mg/dL)      89.87±13.05        88.96±15.80         89.85±16.08          90.95±8.43          0.98
  Cu/Zn           1.54±0.45          2.00±1.53           1.73±0.62            2.10±0.88           0.143

^a^Based on Krumeich KC classification.[@ref27] 25OHD: 25-hydroxyvitamin D, Se: Selenium, Zn: Zinc, Cu: Copper

### Comparison of the serum levels of Zinc, Copper, and Selenium between the study groups {#sec3-2}

Serum level of Zn, Cu, and Se was significantly different between the case and control groups (*P* = 0.015, *P* = 0.004, and *P* = 0.038, respectively). Serum trace element concentrations were lower in KC patients than in the controls \[[Table 1](#T1){ref-type="table"}\].

No statistically significant difference was found between the 4 KC stages regarding mean serum Zn, Cu, and Se (*P* = 0.130, *P* = 0.98, and *P* = 0.113, respectively). In post hoc pairwise comparison, there was no significant difference between KC stages, for serum level of Zn, Se, and Cu (*P* \> 0.05 for all).

According to [Table 2](#T2){ref-type="table"}, in comparison between KC stages, Zn and Se parameters showed *P* \< 0.2 significance level and were entered in multinomial regression analysis. This model showed that Zn and Se serum levels were not significant affecting factors on KC stages (*P* = 0.08 and *P* = 0.072, respectively).

Cu to Zn ratio was not significantly different between the cases and controls (*P* = 0.168) \[[Table 1](#T1){ref-type="table"}\]. Also, the Cu/Zn ratio was not markedly different between KC stages (*P* = 0.143) \[[Table 2](#T2){ref-type="table"}\].

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

In recent years, vitamin D deficiency has been proposed as a global public health problem, and a high prevalence of hypovitaminosis D has been reported in all age groups, especially in those from the Middle East.[@ref13][@ref14][@ref15][@ref16] KC is a prevalent disorder among people who live in developing countries.[@ref2][@ref3][@ref4][@ref14] Vitamin D deficiency has been proven to be associated with higher risk of atopic diseases such as atopic dermatitis, some malignancies, and inflammatory and auto-immune disorders.[@ref29] Interestingly, ocular surface abnormalities like KC are more common in some of these diseases.[@ref30][@ref31][@ref32][@ref33][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39] Recent studies suggest a possible role of vitamin D in reducing oxidative stress.[@ref40] Animal studies have reported the antioxidative role of vitamin D in the treatment of diabetes mellitus in mice.[@ref10] Many parts of the eye contain vitamin D receptors, including the lens, corneal epithelium and endothelium, retinal photoreceptors, and retinal pigment epithelium.[@ref41] Vitamin D deficiency may interfere with the wound healing process, corneal epithelial and tight junction integrity, and gap junctions.[@ref11] It has been demonstrated that vitamin D deficiency can affect the ocular surface by inflammatory, apoptotic, or oxidative mechanisms.[@ref40]

The results of our study showed that the mean serum level of 25OHD and Zn, in the case and control groups, were lower than normal which is in concordance with previously highly recorded vitamin D and Zn deficiency in our country. However, serum 25OHD was significantly different between the KC and normal groups. Although a lower serum 25OHD was found in patients with higher stages of KC, it was not significantly different between the KC stage groups. However, a lower vitamin D level in KC patients compared to healthy subjects, and serum level reduction of 25OHD with increasing KC stage, reveals a possible correlation between these factors. Similar to our results, Akkaya and Ulusoy,[@ref42] in a recent study, found lower serum level of 25OHD in KC patients. Although there was no significant difference between KC stages, they found higher rates of vitamin D deficiency in severe stages of KC. They stated that the low level of vitamin D can be related to the role of immunity and inflammation in the development of ectasia.

Recent studies have shown that hypovitaminosis D is highly prevalent in the Middle East[@ref13][@ref15][@ref16] which makes it critical to assess short and long-term outcomes of this deficiency and to investigate its probable contributions to other prevalent disorders including KC which are prevalent in this geographical area.

Antioxidant defense mechanisms are abnormal in KC corneas, and higher levels of oxidative byproducts such as nitrates are seen.[@ref43] Furthermore, it has been proposed that the accumulation of oxidative cytotoxic byproducts in KC corneas is due to the absence of defensive mechanisms such as catalase, SOD, and glutathione peroxidase which can eliminate them.[@ref44] Also, changes in the stress response of KC corneas can strongly alter the keratocytes\' matrix production in stromal tissue.[@ref45] To investigate the role of oxidative stress on the development and progression of KC, several studies have investigated the serum levels of some trace elements in KC patients and compared them with healthy subjects. Cu dependent enzymes such as SODs and lysyl oxidase alter in KC corneas.[@ref44] Dudakova *et al*.[@ref20] proposed Cu imbalance in corneal tissue as a risk factor for KC. Kilic *et al*.[@ref46] found no significant difference for plasma level of Cu between KC and normal subjects, but similar to our findings, they found a lower level of Zn in KC patients. Kilic mentioned that the small sample size for SOD and Cu was a limitation for their study. However, similar to our results, they found no significant difference for Cu and Zn in different KC stages. Research has proved that Zn acts as an antioxidant and anti-inflammatory agent.[@ref23] Ortak *et al*.[@ref47] and his colleagues documented a significantly lower concentration of Zn and matrix metalloproteinase-2 (MMP-2) in plasma samples of KC patients. Bamdad *et al*.,[@ref18] reported similar findings. They found decreased serum levels of Cu, Zn, and Se in serum samples of patients with advanced KC compared to normal subjects. They also reported a marked association between serum levels of Cu and Zn in advanced KC. In our study, we included KC patients of 4 stages (according to Krumeich KC classification). In agreement with previous reports, our results showed a lower amount of Cu, Zn, and Se in the KC group compared to the normal group. Although it was not significantly different between the 4 KC stages, our findings showed an association between serum level of Zn and stage of KC. In concordance with previous reports,[@ref18] a lower serum level of Zn was seen in patients with more advanced KC, which reveals the possible role of Zn as an etiology of KC.

Previous studies have shown that, there is a relationship between Cu/Zn ratio and oxidative stress.[@ref48] It has also been reported that elevated Cu/Zn ratio is associated with increased oxidative stress and inflammation.[@ref49] Our findings showed relatively elevated Cu/Zn ratios both in controls and cases. Although it was not significant in different KC stages, higher amount of Cu/Zn ratio in KC patients can be related to oxidative stress and inflammatory nature of the KC.

Serum Se was markedly different between the normal and KC subjects. In agreement with previous reports,[@ref18] we found a lower amount of Se in serum samples of KC patients in comparison with the normal group, but it was not related to the stage of KC. The antioxidative role of Se has been proposed in the etiology of KC,[@ref18] and Higuchi *et al*.[@ref50] have shown that a key molecule which carries Se is selenoprotein P which plays an important role in protecting the ocular surface against oxidative stress.

In conclusion, the results of this study indicate lower serum levels of 25OHD, Cu, Zn, and Se in patients with KC, compared to the healthy control group. Considering that this is the first work to report the association between KC and vitamin D deficiency, the findings need to be verified by studies with a larger sample size with different KC stage groups. The results also strengthen the idea that supplemental use of vitamin D and aforementioned antioxidant agents may play a role in the prevention or stopping of the progression of KC.
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